Proteomics and Lipidomics Core

蛋白质组学和脂质组学核心

基本信息

  • 批准号:
    10711696
  • 负责人:
  • 金额:
    $ 30.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-01 至 2028-08-31
  • 项目状态:
    未结题

项目摘要

Proteomics and Lipidomics Core (C. Vary, Core Director) The Proteomics and Lipidomics Core is led by Calvin Vary PhD and provides high quality research design support, sample preparation, mass spectrometry analysis, data collection, and data analysis for a variety of tissues and cells. As a component of the COBRE in Mesenchymal and Neural Regulation of Metabolic Networks since 2017, our services have focused on protein and lipid profiling in mouse and human tissues. Our goals remain to: 1) provide new approaches that expand previous protein identification capabilities, 2) provide unbiased analytic workflows for proteomics and lipidomics studies that include 3) further developing targeted protein (e.g., MRMHR, SRM) and lipid quantitation (MSMSALL, MPIS) workflows, and 4) provide improved statistical and informatics approaches for data interpretation and identification of mechanisms. In Phase I of this COBRE, the Proteomics and Lipidomics Core consistently supported basic, translational, and clinical research projects and grant applications. These have included young investigator-initiated COBRE projects, COBRE pilot projects, and other NIH research applications, both within and outside of MaineHealth Institute for Research. A significant Phase I accomplishment was the award of an NIH S10 shared instrument grant in support of a new high resolution TripleToF mass spectrometer, liquid chromatograph, and other support equipment. MaineHealth provided institutional funds to renovate the facility, which consolidated the current and new equipment in a more efficient footprint. This support has increased our capacity, efficiency, and flexibility by allowing expanded proteomics and lipidomics workflows and increased user access, while providing new opportunities to support ongoing research and training for internal and external users. In phase I, we recruited an outstanding mass spectrometry technology manager, Carlos Gartner PhD, who brought expertise that includes mass spectrometry instrumentation and advanced liquid chromatography. We also recruited Yulica Santos-Ortega, PhD as a research associate with mass spectrometry-based cardiovascular proteomics experience. New Phase II opportunities include exploitation of human proteome-wide selected reaction monitoring protocols using on-line data repositories that will be implemented on new instrumentation (Sciex QTRAP 6500+). We continue to be uniquely positioned as the only regional facility of its kind providing these services for scientific inquiry and in support of student, investigator, and staff training. Within this COBRE, these resources will be critical for promoting junior investigator advancement. This core will advance our understanding of the properties of thermogenic adipocyte lineages and roles in energy balance (Project 1, M. Lynes), provide insight into the role of the X/A cell secretome on bariatric surgery-related bone loss (Project 2, Z. Li). This core will also be well positioned to support PI progress and future exploratory directions for identification of modifiable risk factors in cardiometabolic disease (Project 3, I. Agarwal).
蛋白质组学和脂质组学核心(C. Vary,核心主任)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Calvin Pardee Hull Vary其他文献

Calvin Pardee Hull Vary的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Calvin Pardee Hull Vary', 18)}}的其他基金

Core B: Proteomics and Lipidomics Core
核心 B:蛋白质组学和脂质组学核心
  • 批准号:
    9210670
  • 财政年份:
    2017
  • 资助金额:
    $ 30.92万
  • 项目类别:
Core B: Proteomics and Lipidomics Core
核心 B:蛋白质组学和脂质组学核心
  • 批准号:
    10246816
  • 财政年份:
    2017
  • 资助金额:
    $ 30.92万
  • 项目类别:
CORE B PROTEIN, NUCLEIC ACID ANALYSIS AND CELL IMAGING
核心 B 蛋白、核酸分析和细胞成像
  • 批准号:
    7959653
  • 财政年份:
    2009
  • 资助金额:
    $ 30.92万
  • 项目类别:
Regulation of TGF-beta Receptor-dependent Vascular Disease
TGF-β 受体依赖性血管疾病的调节
  • 批准号:
    7838891
  • 财政年份:
    2009
  • 资助金额:
    $ 30.92万
  • 项目类别:
CORE B PROTEIN, NUCLEIC ACID ANALYSIS AND CELL IMAGING
核心 B 蛋白、核酸分析和细胞成像
  • 批准号:
    7720093
  • 财政年份:
    2008
  • 资助金额:
    $ 30.92万
  • 项目类别:
CORE B PROTEIN, NUCLEIC ACID ANALYSIS AND CELL IMAGING
核心 B 蛋白、核酸分析和细胞成像
  • 批准号:
    7609687
  • 财政年份:
    2007
  • 资助金额:
    $ 30.92万
  • 项目类别:
Regulation of TGF-beta Receptor-dependent Vascular Disease
TGF-β 受体依赖性血管疾病的调节
  • 批准号:
    7586701
  • 财政年份:
    2007
  • 资助金额:
    $ 30.92万
  • 项目类别:
Regulation of TGF-beta Receptor-dependent Vascular Disease
TGF-β 受体依赖性血管疾病的调节
  • 批准号:
    7448001
  • 财政年份:
    2007
  • 资助金额:
    $ 30.92万
  • 项目类别:
Regulation of TGF-beta Receptor-dependent Vascular Disease
TGF-β 受体依赖性血管疾病的调节
  • 批准号:
    7262739
  • 财政年份:
    2007
  • 资助金额:
    $ 30.92万
  • 项目类别:
SMAD-INDEPENDENT TGF-BETA SIGNALING MECHANISMS IN ANGIOGENESIS
血管生成中独立于 SMAD 的 TGF-β 信号传导机制
  • 批准号:
    7609693
  • 财政年份:
    2007
  • 资助金额:
    $ 30.92万
  • 项目类别:

相似国自然基金

相似海外基金

New development of cellular regeneration therapy in jaw bone using stem cells derived from adipocytes jaw bone
利用颌骨脂肪细胞来源的干细胞进行颌骨细胞再生治疗的新进展
  • 批准号:
    23K16058
  • 财政年份:
    2023
  • 资助金额:
    $ 30.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A novel mechanism of insulin resistance mediated by uric acid metabolism in adipocytes
脂肪细胞尿酸代谢介导胰岛素抵抗的新机制
  • 批准号:
    23K10969
  • 财政年份:
    2023
  • 资助金额:
    $ 30.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
  • 批准号:
    10751284
  • 财政年份:
    2023
  • 资助金额:
    $ 30.92万
  • 项目类别:
Development of adipocytes for gene therapy that avoids cellular stress due to overexpression of therapeutic proteins
开发用于基因治疗的脂肪细胞,避免因治疗蛋白过度表达而造成的细胞应激
  • 批准号:
    23H03065
  • 财政年份:
    2023
  • 资助金额:
    $ 30.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis of bitter taste receptors in adipocytes and hepatocytes
脂肪细胞和肝细胞中苦味受体的功能分析
  • 批准号:
    23K05107
  • 财政年份:
    2023
  • 资助金额:
    $ 30.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of mechanisms for conversion of adipocytes to cancer-associated fibroblasts in osteosarcoma microenvironment
阐明骨肉瘤微环境中脂肪细胞转化为癌症相关成纤维细胞的机制
  • 批准号:
    23K19518
  • 财政年份:
    2023
  • 资助金额:
    $ 30.92万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Study on UCP-1 independent metabolic regulation by brown adipocytes
棕色脂肪细胞对UCP-1独立代谢调节的研究
  • 批准号:
    23K18303
  • 财政年份:
    2023
  • 资助金额:
    $ 30.92万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis
脂肪细胞中的 NKA/CD36 信号传导促进氧化应激并驱动动脉粥样硬化的慢性炎症
  • 批准号:
    10655793
  • 财政年份:
    2023
  • 资助金额:
    $ 30.92万
  • 项目类别:
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
  • 批准号:
    23K05594
  • 财政年份:
    2023
  • 资助金额:
    $ 30.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterizing breast cancer invasion and proliferation when co-aggregated with adipocytes in multicellular spheroids created with a custom bioreactor to augment cell-cell connectivity.
当与多细胞球体中的脂肪细胞共聚集时,表征乳腺癌的侵袭和增殖,该多细胞球体是用定制生物反应器创建的,以增强细胞间的连接。
  • 批准号:
    10334113
  • 财政年份:
    2022
  • 资助金额:
    $ 30.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了